Björn Lengenfelder

Impact of treatment delay on mortality in ST-segment elevation myocardial infarction (STEMI) patients presenting with and without haemodynamic instability: results from the German prospective, multicentre FITT-STEMI trial

Karl Heinrich Scholz, Sebastian K.G. Maier, Lars S. Maier et al. · European Heart Journal · 2018 · 353 citations · Full text

effect of additional temporary glycoprotein IIb/IIIa receptor inhibition on troponin release in elective percutaneous coronary interventions after pretreatment with aspirin and clopidogrel (TOPSTAR trial)

Andreas Bonz, Björn Lengenfelder, Jörg Strotmann et al. · Journal of the American College of Cardiology · 2002 · 119 citations · Full text

Thrombosis, Percutaneous Coronary Intervention, Topstar Trial +12

Impact of COVID-19 outbreak on regional STEMI care in Germany

Karl Heinrich Scholz, Björn Lengenfelder, Christian Thilo et al. · Clinical Research in Cardiology · 2020 · 72 citations · Full text

Cytokine response after percutaneous coronary intervention in stable angina: Effect of selective glycoprotein IIb/IIIa receptor antagonism

Andreas Bonz, Björn Lengenfelder, Martina Jacobs et al. · American Heart Journal · 2003 · 39 citations

Inflammation, Thrombosis, Percutaneous Coronary Intervention +11

Treatment of symptomatic hyponatremia with hypertonic saline: a real-life observational study

Irina Chifu, Amelie Gerstl, Björn Lengenfelder et al. · European Journal of Endocrinology · 2021 · 35 citations · Full text